Business
EU regulators reviewing J&J’s COVID vaccine after blood clots – Aljazeera.com
Johnson & Johnson is working with EU regulators to assess data on the rare clots, the company said in a statement.
The European Unions drug regulator has started a review to assess blood clots in people who received Johnson & Johnsons Covid-19 vaccine.
Four serious cases of unusual clots accompanied by low blood platelets, one of which was fatal, have emerged after immunization with the J&J shot, the European Medicines Agency said Friday. The regulator is now scrutinizing potential safety issues for two Covid vaccines, after AstraZeneca Plcs shot was possibly linked to a rare blood-clotting disorder.
J&J is…
-
General22 hours agoAnge Postecoglou returns to Premier League management with Nottingham Forest after Nuno Espírito Santo sacking
-
Business19 hours agoBrokers name 3 quality ASX 200 shares to buy today
-
Business17 hours agoMorgans says these ASX shares could rise 30%+
-
General21 hours agoExplosions heard in Qatar capital Doha, Israel announces strike on Hamas ‘senior leadership’